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Abstract
Linear mixed modelling is a popular approach for detecting and correcting spurious sample
correlations due to hidden confounders in genome-wide gene expression data. In applica-
tions where some confounding factors are known, estimating simultaneously the contribu-
tion of known and latent variance components in linear mixed models is a challenge that
has so far relied on numerical gradient-based optimizers to maximize the likelihood func-
tion. This is unsatisfactory because the resulting solution is poorly characterized and the
efficiency of the method may be suboptimal. Here we prove analytically that maximum-
likelihood latent variables can always be chosen orthogonal to the known confounding
factors, in other words, that maximum-likelihood latent variables explain sample covari-
ances not already explained by known factors. Based on this result we propose a restricted
maximum-likelihood method which estimates the latent variables by maximizing the like-
lihood on the restricted subspace orthogonal to the known confounding factors, and show
that this reduces to probabilistic PCA on that subspace. The method then estimates the
variance-covariance parameters by maximizing the remaining terms in the likelihood func-
tion given the latent variables, using a newly derived analytic solution for this problem.
Compared to gradient-based optimizers, our method attains equal or higher likelihood val-
ues, can be computed using standard matrix operations, results in latent factors that don’t
overlap with any known factors, and has a runtime reduced by several orders of magnitude.
We anticipate that the restricted maximum-likelihood method will facilitate the application
of linear mixed modelling strategies for learning latent variance components to much larger
gene expression datasets than currently possible.
1 Introduction
Following the success of genome-wide association studies (GWAS) in mapping the genetic
architecture of complex traits and diseases in human and model organisms [1–3], there is
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nowadays a great interest in complementing these studies with molecular data to under-
stand how genetic variation affects epigenetic and gene expression states [4–6]. In GWAS, it
is well-known that population structure or cryptic relatedness among individuals may lead
to confouding that can alter significantly the outcome of the study [7]. When dealing with
molecular data, this is further exacerbated by the often unknown technical or environmental
influences on the data generating process. This problem is not confined to population-based
studies – in single-cell analyses of gene expression, hidden subpopulations of cells and an
even greater technical variability cause significant expression heterogeneity that needs to be
accounted for [8].
In GWAS, linear mixed models have been hugely successful in dealing with confounding
due to population structure [7,9–12]. In these models, it is assumed that an individual’s trait
value is a linear function of fixed and random effects, where the random effects are normally
distributed with a covariance matrix determined by the genetic similarities between indi-
viduals, hence accounting for confounding in the trait data. Linear mixed models have also
become popular in the correction for hidden confounders in gene expression data [13–15],
generally outperforming approaches based on principal component analysis (PCA), the sin-
gular value decomposition or other hidden factor models [16–18]. In this context, estimating
the latent factors and the sample-to-sample correlations they induce on the observed high-
dimensional data is the critical problem to solve.
If it is assumed that the observed correlations between samples are entirely due to latent
factors, it can be shown that the resulting mixed model is equivalent to probabilistic PCA,
which can be solved analytically in terms of the dominant eigenvectors of the sample covari-
ance matrix [19,20]. However, in most applications, some confounding factors are known in
advance (e.g. batch effects, genetic factors in population-based studies, or cell-cycle stage in
single-cell studies), and the challenge is to estimate simultaneously the contribution of the
known as well as the latent factors. This has so far relied on the use of numerical gradient-
based optimizers to maximize the likelihood function [8, 15]. This is unsatisfactory because
the resulting solution is poorly characterized, the relation between the known and latent fac-
tors is obscured, and both the solution and the efficiency of the method may be suboptimal
and dependent on the choice of initialization.
Intuitively, latent variables should explain sample covariances not already explained by
known confounding factors. Here we demonstrate analytically that this intuition is correct:
latent variables can always be chosen orthogonal to the known factors without reducing the
likelihood or variance explained by the model. Based on this result we propose a method
that is conceptually analogous to estimating fixed and random effects in linear mixed models
using the restricted maximum-likelihood (REML) method, where the variance parameters
of the random effects are estimated on the restricted subspace orthogonal to the maximum-
likelihood estimates of the fixed effects [21]. Our method, called LVREML, similarly estimates
the latent variables by maximizing the likelihood on the restricted subspace orthogonal to
the known factors, and we show that this reduces to probabilistic PCA on that subspace.
It then estimates the variance-covariance parameters by maximizing the remaining terms
in the likelihood function given the latent variables, using a newly derived analytic solu-
tion for this problem. Similarly to the REML method for conventional linear mixed models,
the LVREML solution is not guaranteed to maximize the total likelihood function. However
we prove analytically that for any given number p of latent variables, the LVREML solution
attains minimal unexplained variance among all possible choices of p latent variables, ar-
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guably a more intuitive and easier to understand criterion.
It is important to emphasize that our solution pertains to the estimation of the overall sample-
to-sample covariance matrix to be used in the linear mixed model for expression heterogene-
ity, and not to the downstream estimation of variance parameters for individual genes given
this covariance matrix. The latter remains a non-convex optimization problem for which
numerical optimizers are required [11, 12].
2 Results
2.1 Restricted maximum-likelihood solution for a linear mixed model with known
and latent variance components
Our initial model to infer latent variance components in a gene expression data matrix is the
same model that was popularized in the widely used PANAMA [15] and scLVM [8] softwares,
where a linear relationship is assumed between expression levels and the known and latent
factors, with random noise added (SI Section S2). In matrix notation, the model can be
written as
Y = ZV + XW + e, (1)
where Y ∈ Rn×m is a matrix of gene expression data for m genes in n samples, and Z ∈ Rn×d
and X ∈ Rn×p are matrices of values for d known and p latent confounders in the same n
samples. The columns vi and wi of the random matrices V ∈ Rd×m and W ∈ Rp×m are the
effects of the known and latent confounders, respectively, on the expression level of gene i,
and are assumed to be jointly normally distributed:
p
([
vi
wi
])
= N
(
0,
[
B D
DT A
])
where B ∈ Rd×d, A ∈ Rp×p and D ∈ Rd×p are the covariances of the known-known, latent-
latent and known-latent confouder effects, respectively. Lastly, e ∈ Rn×m is a matrix of inde-
pendent samples of a Gaussian distribution with mean zero and variance σ2, independent
of the confounding effects.
Previously, this model was considered with independent random effects (B and A diagonal
and D = 0) [8, 15]. As presented here, the model is more general and accounts for possible
lack of independence between the effects of known covariates. Furthermore, allowing the
effects of the known and latent factors to be dependent (D 6= 0) is precisely what will allow
the latent variables to be orthogonal to the known confounders (SI Section S6). An equiv-
alent model with D = 0 can be considered, but requires non-orthogonal latent variables to
explain part of the sample covariance matrix, resulting in a mathematically less tractable
framework. Finally, it remains the case that we can always choose A to be diagonal, be-
cause the latent factors have an inherent rotational symmetry that allows any non-diagonal
model to be converted to an equivalent diagonal model (SI Section S5). By definition, the
known covariates correspond to measured or “natural” variables, and hence they have no
such rotational symmetry.
Using standard mixed-model calculations to integrate out the random effects (SI Section S2),
the log-likelihood of the unknown model parameters given the observed data can be written
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as
Ł
(
X, A, B, σ2 | Y, Z) = − log det(K)− tr(K−1C), (2)
where
K = ZBZT + ZDXT + XDTZT + XAXT + σ21, (3)
and C = (YYT)/m is the empirical sample covariance matrix. Maximizing the log-likelihood
(2) over positive definite matrices K without any further constraints would result in the
estimate Kˆ = C (note that C is invertible because we assume that the number of genes m is
greater than the number of samples n) [22].
If K is constrained to be of the form K = XAXT + σ21 for a given number of latent factors
p < n, then the model is known as probabilistic PCA, and the likelihood is maximized
by identifying the latent factors with the eigenvectors of C corresponding to the p largest
eigenvalues [19, 20]. In matrix form, the probabilistic PCA solution can be written as
Kˆ = P1CP1 + σˆ2P2, (4)
where P1 and P2 are mutually orthogonal projection matrices on the space spanned by the
first p and last n− p eigenvectors of C, respectively, and the maximum-likelihood estimate
σˆ2 is the average variance explained by the n− p excluded dimensions (SI Section S5).
If K is constrained to be of the form K = ZBZT + σ21, the model is a standard linear mixed
model with the same design matrix Z for the random effects vi for each gene i. In general,
there exists no analytic solution for the maximum-likelihood estimates of the (co)variance
parameter matrix B in a linear mixed model [21]. However in the present context it is as-
sumed that the data for each gene is an independent sample of the same mixed model. Again
using the fact that C = (YYT)/m is invertible due to the number of genes being greater than
the number of samples, the maximum-likelihood solution for B, and hence K, can be found
analytically in terms of C and the singular value decomposition (SVD) of Z. It turns out to be
of the same form (4), except that P1 now projects onto the subspace spanned by the known
covariates (the columns of Z) (SI Section S4).
In the most general case where K takes the form (3), we show first that every model of the
form (1) can be rewritten as a model of the same form where the hidden factors are orthog-
onal to the known covariates, XTZ = 0. The reason is that any overlap between the hidden
and known covariates can be absorbed in the random effects vi by a linear transformation,
and therefore simply consists of a reparameterization of the covariance matrices B and D
(SI Section S6.1). Once this orthogonality is taken into account, the log-likelihood (2) de-
composes as a sum Ł = Ł1 + Ł2, where Ł2 is identical to the log-likelihood of probabilistic
PCA on the reduced space that is the orthogonal complement to the subspace spanned by the
known covariates (columns of Z). Analogous to the restricted maximum-likelihood (REML)
method for ordinary linear mixed models, where variance parameters of the random ef-
fects are estimated in the subspace orthogonal to the maximum-likelihood estimates of the
fixed effects [21, 23], we estimate the latent variables X by maximizing only the likelihood
term Ł2 corresponding to the subspace where these X live (Section S6.2). Once the restricted
maximum-likelihood estimates Xˆ are determined, they become “known” covariates, allow-
ing the covariance parameter matrices to be determined by maximizing the remaining terms
Ł1 in the likelihood function using the analytic solution for a model with known covariates
(Z, Xˆ) (Section S6.3).
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Figure 1: A. Distribution of the expression variance explained by individual SNPs in the
Human Liver Cohort. B. Number of linearly independent SNPs selected as covariates as a
function of the parameter θ, the minimum variance explained by each covariate. C. Number
of hidden covariates inferred by LVREML as a function of the parameter ρ, the total amount
of variance explained by the known and latent variables, with θ set to have 0, 5, 10, or 20
known covariates in the model.
By analogy with the REML method, we call our method the restricted maximum-likelihood
method for solving the latent variable model (1), abbreviated “LVREML”. While the LVREML
solution is not guaranteed to be the absolute maximizer of the total likelihood function, it is
guaranteed analytically that for any given number p of latent variables, the LVREML solution
attains minimal unexplained variance among all possible choices of p latent variables (SI
Section S6.4).
2.2 LVREML, a flexible software package for learning latent variance components
in gene expression data
We implemented the restricted maximum-likelihood method for solving model (1) in a soft-
ware package LVREML, available with Matlab and Python interfaces at https://github.
com/michoel-lab/lvreml. LVREML takes as input a gene expression matrix Y, a covariate
matrix Z, and a parameter ρ, with 0 < ρ < 1. This parameter is the desired proportion of
variation in Y that should be explained by the combined known and latent variance compo-
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nents. Given ρ, the number of latent factors p is determined automatically (SI Section S7).
LVREML centres the data Y such that each sample has mean value zero, to ensure that no
fixed effects on the mean need to be included in the model (SI Section S3).
When the number of known covariates (or more precisely the rank of Z) exceeds the number
of samples, as happens in eQTL studies where a large number of SNPs can act as covariates
[15], a subset of n linearly independent covariates will always explain all of the variation in Y.
In [15], a heuristic approach was used to select covariates during the likelihood optimization,
making it difficult to understand a priori which covariates will be included in the model and
why. In contrast, LVREML includes a function to perform initial screening of the covariates,
solving for each one the model (1) with a single known covariate to compute the variance
βˆ2 explained by that covariate alone (SI Section S4). This estimate is then used to include
in the final model only those covariates for which βˆ2 ≥ θ tr(C), where θ > 0 is the second
free parameter of the method, namely the minimum amount of variation a known covariate
needs to explain on its own to be included in the model (SI Section S7).
To illustrate the effect of these parameters, we used data from the Human Liver Cohort
(HLC) [24]. After removing SNPs and genes with missing data, expression data for 31,178
genes and genotype data for 49,879 SNPs in 178 publicly available samples were used for the
analysis (Methods Section 4.2). Individual SNPs explained upto 19% of the variation in Y,
according to the single-covariate model (SI Section S4, eq. (S15)) (Fig. 1A). To illustrate how
the number of inferred hidden covariates varies as a function of the input parameter ρ, we
determined values of the parameter θ to include between 0 and 20 SNPs as covariates in the
model (Fig. 1B). As expected, for a fixed number of known covariates, the number of hidden
covariates increases with ρ, as more covariates are needed to explain more of the variation
in Y (Fig. 1C).
Perhaps counterintuitively, for a fixed number of known covariates, there is a threshold for
ρ below which the inferred number of hidden covariates does not change; moreover both
the threshold and the number of hidden covariates are higher when more known covariates
are included. This is due to a mathematical property of the model: the maximizing solution
exists only if the minimum amount of variation in Y explained by a principal axis in the
space spanned by the known covariates is greater than the maximum-likelihood estimate of
the residual variance σˆ2 (see Theorems 1 and 4 in SI Sections S4 and S6). If non-informative
variables are included among the known covariates, then the minimum variation explained
by them becomes small, and potentially smaller than the residual variance, whose initial
‘target’ value is 1− ρ. Because LVREML considers the known covariates as fixed, it lowers
the value of σˆ2 by including more hidden covariates in the model, until the existence condi-
tion is satisfied. Hence, in Fig. 1C, with 5 known covariates, LVREML cannot build a model
that explains less than 65% of the variation in Y, without violating the existence condition,
whereas with the 48 known covariates this increases to 85% of the variation. Hence it is im-
portant to run the initial covariate screening function to avoid including known covariates
that explain only a very small proportion of variation in the expression data.
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Figure 2: Log-likelihood values for LVREML (A,C) and PANAMA (B,D) using 0, 5, 10, and 20
principal components of the expression data (A,B), and sets of linearly independent SNPs
(C,D) as known covariates, using data from the Human Liver Cohort.
2.3 LVREML infers hidden factors that are non-overlapping with known covari-
ates, and attains likelihood values higher than or equal to PANAMA
To compare the analytic solution of LVREML against the original model with gradient-based
optimization algorithm, we performed a controlled comparison using the PANAMA soft-
ware [15]. We first calculated the principal components (PCs) of the HLC expression data,
and then ran both LVREML and PANAMA using the first 0, 5, 10, and 20 PCs as known covari-
ates. Because of the mathematical properties of the model and the LVREML solution, if the
first d PCs are included as known covariates, LVREML will return the next p PCs as hidden
factors. Hence the log-likelihood of the LVREML solution with d PCs as known covariates
and p hidden factors will coincide with the log-likelihood of the solution with zero known
covariates and d + p hidden factors (that is, probabilistic PCA with d + p hidden factors).
Fig. 2A shows that this is the case indeed: the log-likelihood curves for 0, 5, 10, and 20 PCs
as known covariates are shifted horizontally by a difference of exactly 5 (from 0, to 5, to 10)
or 10 (from 10 to 20) hidden factors.
In contrast, PANAMA did not find the optimal shifted probabilistic PCA solution, and its like-
lihood values largely coincided with the solution with zero known covariates, irrespective of
the number of known covariates provided (Fig. 2B). In other words, PANAMA did not use the
knowledge of the known covariates to explore the orthogonal space of axes of variation not
yet explained by the known covariates, instead arriving at a solution where p hidden factors
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Figure 3: Overlap values (inner products) between the first 10 expression data PCs and the
first known (SNP) and latent covariate inferred by LVREML (A), and between the first 10
PANAMA latent factors and the first known (SNP) covariate (B). Results are from the appli-
cation of LVREML and PANAMA on the Human Liver Cohort with 5 known SNP covariates
and 20 latent variables.
appear to explain no more of the variation than p− d PCs orthogonal to the d known PCs. To
verify this, we compared the PANAMA hidden factors to PCs given as known covariates, and
found that in all cases where the curves in Fig. 2B align, the first d hidden factors coincided
indeed with the d PCs used as known covariates.
When SNPs were used as known confounders (using the procedure explained in Section 2.2),
the log-likelihood values did not show the same clear dependence on the number of known
covariates, and did not differ much between the two methods (Fig. 2C,D). The explanation
is that the selected SNPs all overlapped most strongly with the first PC of the expression
data (Fig. 3A), such that in terms of variance explained, and when comparing Fig. 2C to
Fig. 2A, less than one effective degree of freedom is gained by including the SNPs as known
covariates, and the ‘shifted’ log-likelihood curves become nearly indistinguishable from the
probabilistic PCA curve. However, it is still the case that the latent variables inferred by
LVREML represent orthogonal degrees of freedom to the known SNP covariates. In other
words, the dominant PCs represent the main axes of variation in the expression data, and
are partially explained by population structure (genotype data). The LVREML solution then
infers orthogonal latent variables that explain the ‘missing’ portions of the PCs not explained
by genotype data (Fig. 3A).
In contrast, the latent variables inferred by PANAMA again overlapped with the known SNP
covariates supplied to the model (Fig. 3B). In the PANAMA model, covariances among the ef-
fects of the known confounders are assumed to be zero. When these effects in fact have non-
zero covariance, the optimization algorithm will automatically select hidden confounders
that overlap with the known confounders in order to account for these non-zero covariances
(SI Section S6.1), thus resulting in the observed overlap. Hence the common interpretation
of PANAMA factors as new determinants of gene expression distinct from known genetic
factors is problematic.
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Figure 4: Runtime comparison on the Human Liver Cohort between LVREML (A) and
PANAMA (B) for the same parameter settings (number of known/latent factors).
2.4 LVREML is orders of magnitude faster than PANAMA
An analytic solution does not only provide additional insight into the mathematical prop-
erties of a model, but can also provide significant gains in computational efficiency. The
LVREML solution can be computed using standard matrix operations from linear algebra,
for which highly optimized implementations exist in all commonly used programming lan-
guages. Comparison of the runtime of the Python implementations of LVREML and PANAMA
on the HLC data showed around ten thousand-fold speed-up factors, from several minutes
for a single PANAMA run to a few tens of milliseconds for LVREML (Fig. 4). Moreover the run-
time of LVREML does not depend on the number of known or inferred latent factors, whereas
increasing either parameter in PANAMA leads to an increase in runtime (Fig. 4).
3 Discussion
We presented a linear mixed model to estimate simultaneously the contribution of known
and latent variance components in gene expression data, which is closely related to mod-
els that have been used previously in this context [8, 15, 17, 18, 20]. By including additional
parameters in our model to account for non-zero covariances among the effects on gene ex-
pression of known covariates and latent factors, we were able to show that latent factors can
always be taken orthogonal to, and therefore linearly independent of, the known covariates
supplied to the model. This is important, because inferred latent factors are not only used to
correct for correlation structure in the data, but also as new, data-derived ‘phenotypes’, that
is, determinants of gene expression whose own genetic associations are biologically infor-
mative [18]. As shown in this paper, the existing models and their numerical optimization
result in hidden factors that in fact overlap with the known covariates, and hence their value
in uncovering ‘new’ determinants of gene expression must be questioned.
To solve our model, we did not rely on numerical, gradient-based optimizers, but rather
on an analytic restricted maximum-likelihood solution. This solution is based on a decom-
position of the log-likelihood function that allows to identify hidden factors as principal
components of the expression data matrix reduced to the orthogonal complement of the
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subspace spanned by the known covariates. This solution is guaranteed to minimize the
amount of unexplained variation in the expression data for a given number of latent factors,
and is analogous to the widely used restricted maximum-likelihood solution for conven-
tional linear mixed models, where variance parameters of random effects are estimated in
the subspace orthogonal to the maximum-likelihood estimates of the fixed effects.
Having an analytic solution is not only important for understanding the mathematical prop-
erties of a statistical model, but can also lead to significant reduction of the computational
cost for estimating parameter values. Here, even on a small dataset with 178 samples, we
obtained a ten-thousand fold speed-up compared to an existing software that uses gradient-
based optimization.
To conclude, we have derived an analytic restricted maximum-likelihood solution for a
widely used class of linear mixed models for learning latent variance components in gene
expression data with known and unknown confounders. Our solution can be computed in
a highly efficient manner, identifies hidden factors that are orthogonal to the already known
variance components, and results in the estimation of a sample covariance matrix that can
be used for the downstream estimation of variance parameters for individual genes. We
anticipate that the restricted maximum-likelihood method will facilitate the application of
linear mixed modelling strategies for learning latent variance components to much larger
gene expression datasets than currently possible.
4 Methods
4.1 Mathematical methods
All model equations, mathematical results and detailed proofs are described in a separate
Supplementary Information document.
4.2 Data
We used publicly available genotype and gene expression data from the Human Liver Co-
hort [24], downloaded from https://www.synapse.org/#!Synapse:syn4499, and consist-
ing of gene expression data for 40,638 genes in 466 individuals and genotype data for 449,698
SNPs in 195 individuals; 178 individuals had both expression and genotype data and were
used in our analyses. We removed all genes and SNPs with missing data, and further re-
moved SNPs with minor allele frequence less than 5% and that were not in Hardy-Weinberg
equilibrium (P < 10−6). This resulted in gene expression data for 31,178 genes and genotype
data for 49,879 SNPs in 178 samples. Finally, gene expression samples were centred to have
mean zero, and genotype samples were normalized to have unit L2-norm.
4.3 LVREML analyses
The LVREML software, as well as a script that details the LVREML analyses of the HLC data is
available at https://github.com/michoel-lab/lvreml.
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4.4 PANAMA analyses
We obtained the PANAMA software from the LIMIX package available at https://github.
com/limix/limix-legacy.
The following settings were used to ensure that exactly the same normalized data was used
by both methods: 1) For parameter Y, the same gene expression matrix, with each sample
normalized to have zero mean, was used that was used as input for LVREML, setting the
standardize parameter to false. 2) The parameter Ks requires a list of covariance matrices
for each known factor. Therefore for each column zi of the matrix Z used by LVREML we
included the covariance matrix Ksi = zizTi in Ks. The ‘use Kpop’ parameter, which is used
to supply a population structure covariance matrix to PANAMA in addition to the known
covariates, was set to false.
To be able to calculate the log-likelihoods and extract other relevant information from the
PANAMA results, we made the following modifications to the PANAMA code: 1) The covari-
ance matrices returned by PANAMA are by default normalized by dividing the elements of
the matrix by the mean of its diagonal elements. To make these covariance matrices compa-
rable to LVREML this normalization was omitted by commenting out the lines in the original
PANAMA code where this normalization was being performed. 2) PANAMA does not return
the variance explained by the known confounders unless the ‘use Kpop’ parameter is set to
true. Therefore the code was modified so that it would still return the variance explained by
the known confounders. 3) The K matrix returned by PANAMA does not include the effect
of the noise parameter σ2. Therefore the code was modified to return the σ21 matrix, which
was then added to the returned K i.e. Knew = K + σ21, to be able to use equation (2) to
compute the log-likelihood. The modified code is available as a fork of the LIMIX package at
https://github.com/michoel-lab/limix-legacy
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Supplementary Information
S1 Preliminary results
In the sections below, we will repeatedly use the following results. The first result concerns
linear transformations of normally distributed variables and can be found in most textbooks
on statistics or probability theory:
Lemma 1. Let x ∈ Rn be a random, normally distributed vector,
p(x) = N (µ,Ψ),
with µ ∈ Rn, and Ψ ∈ Rn×n a positive definite covariance matrix. For any linear transformation
y = Mx with M ∈ Rm×n, we have
p(y) = N (Mµ, MΨMT).
The second result is one that is attributed to von Neumann [22]:
Lemma 2. Let P, Q ∈ Rn×n be two positive definite matrices. Then
tr(P−1Q) ≥
n
∑
i=1
pi−1i χi, (S1)
where pi1 ≥ · · · ≥ pin and χ1 ≥ · · · ≥ χn are the ordered eigenvalues of P and Q, respectively, and
equality in eq. (S1) is achieved if and only if the eigenvector of P corresponding to pii is equal to the
eigenvector of Q corresponding to χn−i+1, i = 1, . . . , n.
S2 The model
We will use the following notation:
• Y ∈ Rn×m is a matrix of gene expression data for m genes in n samples. The ith column
of Y is denoted yi ∈ Rn and corresponds to the vector of expression values for gene i.
We assume that the data in each sample are centred, ∑mi=1 yi = 0 ∈ Rn.
• Z ∈ Rn×d is a matrix of values for d known confounders in the same n samples. The
kth column of Z is denoted zk ∈ Rn and corresponds to the data for confounding factor
k.
• X ∈ Rn×p is a matrix of values for p latent variables to be determined in the same n
samples. The jth column of X is denoted xj ∈ Rn.
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To identify the hidden correlation structure of the expression data, we assume a linear rela-
tionship between expression levels and the known and latent variables, with random noise
added:
yi = Zvi + Xwi + ei, (S2)
where vi ∈ Rd and wi ∈ Rp are jointly normally distributed random vectors,
p
([
vi
wi
])
= N
(
0,
[
B D
DT A
])
(S3)
with B ∈ Rd×d, D ∈ Rd×p and A = diag(α21, . . . , α2p), such that
Ψ =
[
B D
DT A
]
is a positive definite matrix; the errors ei ∈ Rn are assumed to be independent and normally
distributed,
p(ei) = N (0, σ21).
Note that our aim is to identify variance components shared across genes, and hence σ2 is
assumed to be the same for all i. By assumption, the errors are also independent of the effect
sizes, and hence we can write
p
viwi
ei
 = N
0,
 B D 0DT A 0
0 0 σ21
 . (S4)
By Lemma 1, yi is normally distributed with distribution
p(yi) = N (0, K) = 1
(2pi)
n
2
√
det(K)
exp
(−1
2
〈yi, K−1yi〉
)
, (S5)
where
K =
[
Z X 1
]  B D 0DT A 0
0 0 σ21
ZTXT
1
 = ZBZT + ZDXT + XDTZ + XAXT + σ21,
and we used the notation 〈u, v〉 = uTv to denote the inner product between two vectors in
Rn.
Defining matrices V ∈ Rd×m and W ∈ Rp×m, whose columns are the random effect vectors
vi and wi, respectively, eq. (S2) can be written in matrix notation as
Y = ZV + XW + e
Under the assumption that the columns yi of Y are independent samples of the distribution
(S5), the likelihood of observing Y given covariate data Z, (unknown) latent variable data X
and values for the hyper-parameters Θ = {σ2, A, B, D}, is given by
p(Y | Z, X,Θ) =
m
∏
i=1
p(yi | 0, K).
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Note that in standard mixed-model calculations, the distribution (S5) is often arrived at by
integrating out the random effects. This is equivalent to application of Lemma 1.
To conclude, the log-likelihood is, upto an additive constant, and divided by half the number
of genes:
Ł = − 2
m
[m
2
log det(K) +
1
2
m
∑
i=1
〈yi, K−1yi〉
]
= − log det(K)− tr(K−1C),
where
C =
YYT
m
is the empirical covariance matrix.
S3 Systematic effects on the mean
Eq. (S2) only considers random effects, which leads to a model for studying systematic effects
on the covariance between samples. We could also include fixed effects to model systematic
effects on mean expression level. However, by centering the data,∑mi=1 yi = 0, the maximum-
likelihood estimate of such fixed effects is always zero. To see this, let T ∈ Rn×c be a matrix
of c covariates with fixed effects β ∈ Rc shared across genes (we are only interested in
discovering systematic biases in the data). Then the minus log-likelihood (2) becomes
Ł = log det(K) +
1
m
m
∑
i=1
〈yi − Tβ, K−1(yi − Tβ)〉
Optimizing with respect to β leads to the equation
βˆ = (TTK−1T)−1TT y¯
where
y¯ =
1
m
m
∑
i=1
yi = 0.
S4 Solution of the model without latent variables
We start by considering the problem of finding the maximum-likelihood solution in the ab-
sence of any latent variables, i.e. minimizing eq. (2) with
K = ZBZT + σ21 (S6)
with respect to B and σ2.
Note first of all that we may assume the set of confounding factors {z1, . . . , zd} to be linearly
independent, because if not, the expression in eq. (S2) can be rearranged in terms of a lin-
early independent subset of factors whose coefficients are still normally distributed due to
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elementary properties of the multivariate normal distribution, see for instance the proof of
Lemma 5 below. Linear independence of {z1, . . . , zd} implies that we must have d ≤ n and
rank(Z) = d.
The singular value decomposition allows to decompose Z as Z = UΓVT, where U ∈ Rn×n,
UTU = UUT = 1, Γ ∈ Rn×d diagonal with γ2k ≡ Γkk > 0 for k ∈ {1, . . . , d} [this uses
rank(Z) = d], and V ∈ Rd×d, VTV = VVT = 1. There is also a ‘thin’ SVD, Z = U1Γ1VT,
where U1 ∈ Rn×d, UT1 U1 = 1, Γ1 ∈ Rd×d diagonal with diagonal elements γ2k . In block
matrix notation, U = (U1, U2) and
Z =
(
U1 U2
) (Γ1
0
)
V (S7)
Note that unitarity of U implies UT1 U2 = 0.
Denote byHZ the space spanned by the columns (i.e. covariate vectors) of Z. The projection
matrix PZ ontoHZ is given by
PZ = Z(ZTZ)−1ZT = U1Γ1VT(VΓ−21 V
T)VΓ1UT1 = U1U
T
1 .
Using the basis of column vectors of U, we can write any matrix M ∈ Rn×n as a partitioned
matrix
UTMU =
(
M11 M12
M21 M22
)
(S8)
where
Mij = UTi MUj.
The following results for partitioned matrices are derived easily or can be found in [25]:
tr(M) = tr(M11) + tr(M22) (S9)
det(M) = det
(
M11 −M12M−122 M21
)
det(M22) (S10)
Using this notation, the following result solves the model without latent variables:
Theorem 1. Let C ∈ Rn×n be a positive definite matrix such that
λmin(C11) >
tr(C22)
n− d , (S11)
where λmin(·) denotes the smallest eigenvalue of a matrix. Then the maximum-likelihood solution
Kˆ = argmin
{K : K=ZBZT+σ21}
log det K + tr
(
K−1C
)
, (S12)
subject to B being positive definite and σ2 ≥ 0, is given by
Bˆ = VΓ−11 (C11 − σˆ21)Γ−11 VT (S13)
σˆ2 =
tr(C22)
n− d (S14)
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Proof. Using eq. (S7), we can write
K = ZBZT + σ21 = U1Γ1VTBVΓ1UT1 + σ
2(U1UT1 + U2U
T
2 )
= U1Γ1VT
(
B + σ2VΓ−21 V
T)VΓ1UT1 + σ2U2UT2 .
Hence, in the block matrix notation (S8), we have
K11 = Γ1VT
(
B + σ2VΓ−21 V
T)VΓ1
K22 = σ21
K12 = K21 = 0.
It follows that
K−1 =
(
K−111 0
0 K−122
)
and, using eqs. (S9) and (S10),
log det(K) = log det(K11) + log det(K22) = log det(K11) + (n− d) log(σ2)
tr(K−1C) = tr(K−111 C11) + tr(K
−1
22 C22) = tr(K
−1
11 C11) +
tr(C22)
σ2
.
Let C11 have eigenvalues λ1 ≥ · · · ≥ λd with corresponding eigenvectors u1, . . . , ud ∈ Rd.
Applying Lemma 2 to the term tr(K−111 C11), it follows that for the minimizer Kˆ, Kˆ11 must
have eigenvalues κ1 ≥ · · · ≥ κd with the same eigevectors u1, . . . , ud as C11. Expressing the
minus log-likelihood in terms of these eigenvalues results in
Ł(Kˆ) =
d
∑
i=1
log(κi) +
d
∑
i=1
κ−1i λi + (n− d) log(σ2) +
tr(C22)
σ2
.
Minimizing with respect to the parameters κi and σ2 (i.e., setting their derivatives to zero)
results in the solution κˆi = λi for all i and σˆ2 =
tr(C22)
n−d . In other words, Kˆ11 has the same
eigenvalues and eigenvectors as C11, that is,
Kˆ11 = C11.
This equation is satisfied if
Bˆ + σˆ2VΓ−21 V
T = VΓ−11 C11Γ
−1
1 V
T
or
Bˆ = VΓ−11 (C11 − σˆ21)Γ−11 VT
Bˆ is positive definite if and only if for all v ∈ Rd
0 < 〈v, Bˆv〉 = 〈w, (C11 − σˆ21)w〉,
where w = Γ1Vv. Because V is unitary and Γ1 diagonal with strictly positive elements,
〈v, Bˆv〉 > 0 for all v ∈ Rd if and only if 〈w, (C11 − σˆ21)w〉 > 0 for all w ∈ Rd, or
0 < min
w∈Rd
〈w, C11w〉
〈w, w〉 − σˆ
2 = λmin(C11)− σˆ2.
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Eq. (S11) is a condition on the amount of variation in Y explained by the confounders Z,
with λmin(C11) being (proportional to) the minimum amount of variation explained by any
of the dimensions spanned by the columns of Z, and 1n−d tr(C22) being the average amount
of variation explained by the dimensions orthogonal to the columns of Z. Failure of this
condition simply means that there must be other, latent variables that explain more variation
than the known ones, which is precisely what we are seeking to detect.
A useful special case of Theorem 1 occurs when the number of confounders equals one. In
this case, we are seeking maximum-likelihood solutions for K of the form
K = β2zzT + σ21,
where z ∈ Rn is the confounding data vector. Let γ2 = ‖z‖2 and u = 1γz. Then Pz = uuT is
the projection matrix onto z, C11 = 〈u, Cu〉, and tr(C22) = tr((1− Pz)C) = tr(C)− 〈u, Cu〉.
By Theorem 1, we have
βˆ2 =
1
γ2
{
〈u, Cu〉 − tr
(
[1− Pz]C
)
n− 1
}
=
1
γ2
{
n
n− 1 〈u, Cu〉 −
tr(C)
n− 1
}
(S15)
σˆ2 =
tr
(
[1− Pz]C
)
n− 1 =
tr(C)− 〈u, Cu〉
n− 1 ,
provided
〈u, Cu〉 > tr(C)
n
.
S5 Solution of the model without known covariates
Next, consider a model without known covariates, i.e. with posterior sample covariance
matrix K = KX({αj, xj}) + σ21, where
KX
({αj, xj}) = p∑
j=1
α2j xjx
T
j .
This model is equivalent to probabilistic principal component analysis [19,20], and its maximum-
likelihood solution is given by the first p eigenvectors or principal components with largest
eigenvalues of C. Here we present a more direct proof of this fact than what can be found in
the literature.
Lemma 3. Without loss of generality, we may assume that the latent variables have unit norm, are
linearly independent, and are mutually orthogonal.
Proof. If the latent variables do not have unit norm, define cj = ‖xj‖−1, α′j = αj/cj and
x′j = cjxj for all j. It follows immediately that ‖x′j‖ = 1 and
KX
({αj, xj}) = KX({α′j, x′j}).
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Next assume that the latent variables are not linearly independent, i.e. that rank(KX) = r <
p. Because KX is a symmetric matrix, we must have KX = ∑rl=1 tlt
T
l for some set of linearly
independent vectors tl ∈ Rn. Define α′l = ‖tl‖ and x′l = tl/‖tl‖. Then x′l has unit norm and
KX
({α′l , x′l}) = KX({αj, xj}).
Finally, recall that
KX({αj, xj}) = XAXT = (XA 12 )(XA 12 )T,
where A = diag(α21, . . . , α
2
p). Because we may now assume that rank(X) = p, and because
αj > 0 for all j, the matrix XA
1
2 has singular value decomposition
XA
1
2 = UΞVT
with U ∈ Rn×p, UTU = 1, Ξ ∈ Rp×p diagonal with diagonal elements Ξjj = ξ j > 0, and
V ∈ Rp×p, VTV = VVT = 1. Hence
KX
({αj, xj}) = UΞ2UT = p∑
j=1
ξ2j uju
T
j = KX
({ξ j, uj}),
with uj the orthonormal columns of U, 〈uj, u′j〉 = (UTU)jj′ = δj,j′ .
We will also need the following simple result:
Lemma 4. Let λ1 ≥ λ2 ≥ · · · ≥ λn > 0 be a decreasing sequence of positive numbers, and let
1 ≤ p < n. If there exists j > p such that λp > λj, then
λp >
1
n− p
n
∑
j=p+1
λj. (S16)
Proof. Eq. (S16) follows from
λp − 1n− p
n
∑
j=p+1
λj =
1
n− p
n
∑
j=p+1
(λp − λj) > 0,
because each term on the r.h.s. is non-negative, and at least one is strictly positive.
Theorem 2. Let C ∈ Rn×n be a positive definite matrix with eigenvalues λ1 ≥ · · · ≥ λn and
corresponding eigenvectors u1, . . . , un, and let either p = n or 1 ≤ p < n such that there exists
j > p with λp > λj. Then the maximum-likelihood solution
Kˆ = argmin
{K : K=XAXT+σ21}
log det K + tr
(
K−1C
)
,
is given by
xˆj = uj
αˆ2j = λj − σˆ2
σˆ2 =
1
n− p
n
∑
j=p+1
λj.
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Proof. By Lemma 3, we can assume that X has orthonormal columns, and hence there exist
V ∈ Rn×(n−p) such that Q = (X, V) ∈ Rn×n is unitary, QTQ = QQT = 1. Hence K =
XAXT + σ21 has the spectral decomposition
K =
(
X V
) (A2 + σ21 0
0 σ21
)(
XT
VT
)
,
and hence
K−1 =
p
∑
j=1
1
α2j + σ
2
xjxTj +
1
σ2
n−p
∑
l=1
vlvTl ,
where vl ∈ Rn are the columns of V.
Assume that the α2j are ordered, α
2
1 ≥ · · · ≥ α2p. Applying von Neumann’s Lemma 2 gives
Ł = log det(K) + tr
(
K−1C
)
≥
p
∑
j=1
log(α2j + σ
2) + (n− p) log(σ2) +
p
∑
j=1
λj
α2j + σ
2
+
n
∑
j=p+1
λj
σ2
, (S17)
with equality if and only if
xj = uj for j = 1, . . . , p
vl = up+l for l = 1, . . . , n− p
Hence, independent of the values for αj, the maximum-likelihood latent variables are the
eigenvectors of C corresponding to the p largest eigenvalues. Minimizing eq, (S17) w.r.t. α2j
and σ2 then gives
α2j = λj − σ2
σ2 =
1
n− p
N
∑
j=p+1
λj.
By Lemma 4, α2j > 0 for all j.
Note that plugging the maximum-likelihood values in the likelihood function gives
Łmin =
p
∑
j=1
log(λj) + (n− p) log
( 1
n− p
n
∑
j=p+1
λj
)
+ n (S18)
Either p can be set a priori small enough such that condition (S16) is satisfied, or else the
value of p with smallest Łmin satisfying this condition can be found easily from eq. (S18).
Note also that in the models of [19, 20], uniform prior variances are assumed (α21 = · · · =
α2p = 1), such that X is defined upto an arbitrary rotation, because XXT = (XR)(XR)T for
any rotation matrix R. In our model, there is no such rotational freedom (if A is assumed to
be diagonal), except if C has eigenvalues with multiplicities greater than one, when there is
some freedom to choose the corresponding eigenvectors.
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S6 Solution of the full model
S6.1 Orthogonality of known and hidden confounders
Lemma 5. Without loss of generality, we may assume that the latent variables are orthogonal to the
known confounders:
XTZ = ZXT = 0. (S19)
Proof. As in Section S4, let PZ again be the projection matrix on the space spanned by the
known covariates zk (i.e. the columns of Z). For any choice of latent variables xj, we have
xj = PZxj + (1− PZ)xj =
d
∑
k=1
mkjzk + x˜j,
for some matrix of linear coefficients M = (mkq) ∈ Rd×p, and with 〈sk, x˜j〉 = 0 for all k. Or,
in matrix notation
X = ZM + X˜, with X˜TZ = ZTX˜ = 0
Plugging this in eq. (S2), results in
yi = Zv˜i + X˜wi + ei (S20)
where v˜i = vi + Mwi. Hence  v˜iwi
ei
 =
1 M 00 1 0
0 0 1
viwi
ei

and hence, using Lemma 1, it follows that
p
 v˜iwi
ei
 = N
0,
B + MDT + DMT + MAMT D + AMT 0DT + MA A 0
0 0 σ21
 .
This is still of exactly the same form as eq. (S4). Hence model (S20) is identical to model (S2),
but has hidden covariates orthogonal to the known covariates.
Note that we can parameterize the model with hidden variables orthogonal to the known
confounders, ZTX = 0, but only if we allow the covariances of their effects on gene expres-
sion, Cov(vi, wi) = D, to be non-zero. Equivalently, we can parameterize the model such
that the random effects of hidden variables are statistically independent of the effects of the
known confounders, Cov(vi, wi) = 0, but only if we allow the hidden variables to overlap
with the known confounders, ZTX 6= 0. Mathematically, the choice of orthogonal hidden
factors will be much more convenient.
Note also that a transformation to orthogonal hidden factors always induces non-zero co-
variances among the known confounders via the term MAMT. Hence an important diffi-
culty with the model where B is assumed to be diagonal, as used in [15], comes from the
fact that non-orthogonal hidden variables are needed to model off-diagonal covariances be-
tween the known confounders. It is much more intuitive to model these directly by assuming
a general covariance matrix.
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S6.2 Restricted maximum-likelihood solution for the latent variables
Lemma 6. Without loss of generality, we may assume that the latent variables have unit norm, are
linearly independent, and are mutually orthogonal.
Proof. The proof is identical to the proof of Lemma 3 – it is straightforward to verify that
the transformation to orthonormal variables also do not change the form of the off-diagonal
term ZDXT in the covariance matrix K, but merely lead to a reparameterization of the matrix
D.
To solve the full model, we follow an approach similar to the standard restricted maximum-
lilelihood method for linear mixed models [21, 23]: we write the negative log-likelihood
function Ł = log det(K) + tr(K−1C) as a sum
Ł = Ł1 + Ł2, (S21)
where Ł2 will be the log-likelihood restricted to the subspace orthogonal to the known con-
founders Z. We will estimate the latent variables X and their effect covariances A by max-
imizing Ł2, and estimate the effect covariances B and D involving the known confounders
by maximizing Ł1. Solving for the latent variables on a restricted subspace is motivated by
the observation that if y ∈ Rn is a sample from the model (S2), that is, p(y) = N (0, K), then
U2UT2 y = U2U
T
2 Zv + U2U
T
2 Xw + U2U
T
2 e = Xw + e
′.
In other words, restricted to the subspace orthogonal to Z, the general model becomes a
probablistic PCA model where all variation in the data is explained by the latent variables.
To obtain the decomposition (S21), we partition y ∈ Rn as y = (y1, y2)T, where y1 = UT1 y ∈
Rd and y2 = UT2 y ∈ Rn−d, and write
p(y) = p(y1, y2) = p(y1 | y2)p(y2),
or
log p(y) = log p(y1, y2) = log p(y1 | y2) + log p(y2).
Hence
Ł = − 2
m
m
∑
i=1
log p(yi) = − 2m
m
∑
i=1
log p(yi1 | yi2)︸ ︷︷ ︸
Ł1
− 2
m
m
∑
i=1
log p(yi2)︸ ︷︷ ︸
Ł2
Using standard results for the marginal and conditional distributions of a multivariate Gaus-
sian, we have
p(y2) = N (0, K22)
p(y1 | y2) = N
(
K12K−122 y2, (K11 −K12K−122 K21)
)
,
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where we used the partitioned matrix notation of eq. (S8). In particular,
Ł2 = log det(K22) +
1
m
m
∑
i=1
〈UT2 yi, K−122 UT2 yi〉
= log det(K22) +
1
m
m
∑
i=1
tr
(
K−122 U
T
2 yiy
T
i U2
)
= log det(K22) + tr
(
K−122 C22
)
.
Note that K22 = UT2 XAX
TUT2 + σ
21, and hence Ł2 depends only on X, A and σ2. The re-
stricted maximum likelihood solution for the latent variables follows immediately:
Theorem 3. Let Xˆ ∈ Rn×p, Aˆ ∈ Rd×d, and σˆ2 be the solution of
{Xˆ, Aˆ, σˆ2} = argmin
X,A,σ2
Ł2(X, A, σ2),
where the minimum is taken over all X with XTZ = 0, and all positive definite diagonal matrices Aˆ.
If there exists j > p such that λp > λj, then
Xˆ = U2Wp (S22)
Aˆ = diag(λ1 − σˆ2, . . . ,λp − σˆ2) (S23)
σˆ2 =
1
n− d− p
n−d
∑
j=p+1
λj (S24)
where λ1 ≥ λ2 ≥ · · · ≥ λn−d are the sorted eigenvalues of C22 with corresponding eigenvectors
w1, . . . , wn−d ∈ Rn−d, and Wp = (w1, . . . , wp) ∈ R(n−d)×p is the matrix with the first p eigenvec-
tors of C22 as columns.
Proof. Defining X˜ = UT2 X ∈ R(n−d)×p, we have K22 = X˜AX˜T +σ21, and Ł2 becomes precisely
the minus log-likelihood of the model without known covariates (Section S5), as a function
of the latent variables X˜ on the reduced (n− d)-dimensional space orthogonal to the known
confounders Z. Hence by Theorem 2,
ˆ˜X = Wp
Aˆ = diag(λ1 − σ2, . . . ,λp − σ2),
where λ1 ≥ λ2 ≥ · · · ≥ λn−d are the sorted eigenvalues of C22 and Wp ∈ R(n−d)×p is the
matrix having the corresponding first p eigenvectors as columns. Note that Aˆ is positive
definite by Lemma 4 and the assumption that there exists j > p such that λp > λj. It remains
to ‘pull-back’ X˜ to the original n-dimensional space, using the orthogonality condition (S19):
Xˆ = (U1UT1 + U2U
T
2 )Xˆ = U2U
T
2 Xˆ = U2
ˆ˜X = U2Wp.
This proves eqs. (S22) and (S23).
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S6.3 Solution for the variance parameters given the latent variables
With Xˆ, Aˆ and σˆ2 determined by the minimization of Ł2 in Theorem 3, Ł2(Xˆ, Aˆ, σˆ2) is constant
in terms of the parameters B and D that remain to be optimized. Hence optimizing Ł1
with respect to these parameters is the same as optimizing the total negative log-likelihood
Ł(Xˆ, Aˆ, B, D, σˆ2) w.r.t. B and D. We have:
Theorem 4. Let Bˆ ∈ Rd×d and Dˆ ∈ Rd×(n−d) be the solution of
{Bˆ, Dˆ} = argmin
B,D
Ł1(Xˆ, Aˆ, B, D, σˆ2) = argmin
B,D
Ł(Xˆ, Aˆ, B, D, σˆ2),
subject to the constraint that B and B−DAˆ−1DT are positive definite. If
λmin(C11) > σˆ2, (S25)
then
Bˆ = VΓ−11 (C11 − σˆ21)Γ−11 VT (S26)
Dˆ = VΓ−11 C12Wp (S27)
where as before
Z =
(
U1 U2
) (Γ1
0
)
VT
is the singular value decomposition of Z, and Wp = (w1, . . . , wp) ∈ R(n−d)×p is the matrix with
the first p eigenvectors of C22 as columns.
Proof. Note that the conditions B and B−DAˆ−1DT positive definite are to ensure that the
matrix
(
B D
DT Aˆ
)
is positive definite. Next note that with XˆT known, the covariance matrix
K can be written as
K =
(
Z Xˆ
) ( B D
DT Aˆ
)(
ZT
XˆT
)
+ σˆ21
Hence the total log-likelihood is identical to the model with known covariates Z˜ =
(
Z Xˆ
)
and no latent variables (Section S4). The unconstrained maximizing solution (that is, where
A and σ2 are also optimized) for the model with known covariates Z˜ is given by Theorem 1.
Due to XˆTZ = 0 and the definition of Xˆ, the singular value decomposition of Z˜ is given by
Z˜ =
(
U1 Xˆ U3
)Γ1 00 1
0 0
(VT 0
0 1
)
,
where the columns of U3 ∈ Rn×(n−d−p) span the space orthogonal to the columns of Z˜.
Hence the unconstrained solution, can be written as (cf. eqs. (S13)–(S14))(
Bˆ Dˆ
DˆT Aˆ′
)
=
(
V 0
0 1
)(
Γ−11 0
0 1
)(
UT1
XˆT
)
(C− σˆ′21) (U1 Xˆ) (Γ−11 00 1
)(
VT 0
0 1
)
σˆ′2 =
tr(UT3 CU3)
n− d− p
25
First note that σˆ′2 = σˆ2, because we can write U3 = U2W∼p, where W∼p ∈ R(n−d)×(n−d−p) is
the matrix with the n− d− p last eigenvectors of C22.
Working out the block matrix product results in:
Bˆ = VΓ−11 U
T
1 (C− σˆ21)U1Γ−11 VT = VΓ−11 (C11 − σˆ21)Γ−11 VT
Dˆ = VΓ−11 U
T
1 CXˆ = VΓ
−1
1 U
T
1 CU2Wp = VΓ
−1
1 C12Wp
Aˆ′ = XˆT(C− σˆ21)Xˆ = WTp UT2 (C− σˆ21)U2Wp = WTp (C22 − σˆ21)Wp
= diag(λ1 − σˆ2, . . . ,λp − σˆ2)
Hence, also the estimate Aˆ′ = Aˆ. Because the unconstrained optimization of Ł given Xˆ
results in the same estimate for A and σ2 as the intial constrained optimization where these
parameters were given, it follows that also the estimates of B and D must be the same:
{Bˆ, Dˆ} = argmin
B,D
Ł(B, D | Xˆ, Aˆ, σˆ2) = argmin
B,D
min
A,σ2
Ł(A, B, D, σ2 | Xˆ).
S6.4 LVREML maximizes the variance explained
It is tempting to ask whether the combined solution from Theorems 3 and 4 optimizes the
total likelihood among all possible p-dimensional sets of latent variables. To address this
problem, let X ∈ Rn×p be an arbitrary matrix of latent variables whose columns are nor-
malized, mutually orthogonal and orthogonal to the columns of Z, XTX = 1 and XTZ = 0.
Because U2 is only defined upto a rotation, we can always choose
U2 =
(
X Q
)
with Q ∈ Rn×(n−d−p) satisfying QTQ = 1, QTX = 0 and QTZ = 0. From the proof of
Theorem 4 we immediately obtain:
Proposition 1. Let A(X) ∈ Rp×p, B(X) ∈ Rd×d, D(X) ∈ Rd×(n−d) and σ2(X) > 0 be the
solution of
{A(X), B(X), D(X), σ2(X)} = argmin
A,B,D,σ2
Ł(A, B, D, σ2 | X).
Then
B(X) = VΓ−11 (C11 − σˆ21)Γ−11 VT
D(X) = VΓ−11 U
T
1 CX
A(X) = XT(C− σˆ21)X
σ2(X) =
tr(QTCQ)
n− d− p
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Plugging these values into the negative log-likelihood function results in a function that
depends only on X:
Proposition 2. Let X ∈ Rn×p be an arbitrary choice of latent variables with associated maximum-
likelihood estimates for the covariance parameters given by Proposition 1. Then, upto an additive
constant
ŁX = log det
(
XT
[
C− CU1(UT1 CU1)UT1 C
]
X
)
+ (n− d− p) log(σˆ2(X)) (S28)
Proof. Recall from Theorem 2 that the maximum-likelihood estimate for K given X and its
associated maximum-likelihood parameters estimates is given by
Kˆ(X) =
UT1 CU1 UT1 CX 0XTCU1 XTCX 0
0 0 σˆ21

while the covariance matrix C can be written as
C =
UT1 CU1 UT1 CX UT1 CQXTCU1 XTCX XTCQ
QCU1 QCX QTCQ

Hence
ŁX = Ł
(
Kˆ(X)
)
= log det
(
Kˆ(X)
)
+ tr
(
Kˆ(X)−1C
)
= log det
(
UT1 CU1 U
T
1 CX
XTCU1 XTCX
)
+ (n− d− p) log(σˆ2) + (d + p) + tr(Q
TCQ)
σˆ2
= log det
(
UT1 CU1 U
T
1 CX
XTCU1 XTCX
)
+ (n− d− p) log(σˆ2) + (d + p) + (n− d− p)
Using equation (S10) for the determinant of a partitioned matrix, we have
log det
(
UT1 CU1 U
T
1 CX
XTCU1 XTCX
)
= log det(UT1 CU1) + log det
(
XTCX− XTCU1(UT1 CU1)−1U1CX
)
= log det(UT1 CU1) + log det
(
XT
[
C− CU1(UT1 CU1)−1UT1 C
]
X
)
.
Ignoring the constants log det(UT1 CU1) and n which do not depend on X, we obtain eq. (S28).
Due to the determinant term in eq. (S28), it is not clear whether the restricted maximum-
likelihood solution Xˆ of Theorem 3 (with its associated maximum-likelihood covariance pa-
rameters of Theorem 4) is the absolute minimizer of ŁX,
Xˆ = argmin
X∈Rn×p,XTX=1,XTZ=0
ŁX ?
However, we do have the following result:
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Theorem 5. The restricted maximum-likelihood solution Xˆ of Theorem 3 is the set of p latent vari-
ables that minimizes the residual variance among all choices of p latent variables,
Xˆ = argmin
X∈Rn×p,XTX=1,XTZ=0
σ2(X)
Proof. By Proposition 1 and the arguments leading up to it, we can write
tr(C22) = tr(XTCX) + tr(QTCQT) = tr
(
(UT2 X)
TC22(UT2 X)
)
+ tr
(
(UT2 Q)
TC22(UT2 Q)
)
,
where as before C22 = UT2 CU2 is the restriction of C to the (n − d)-dimensional subspace
orthogonal to the d known covariates, and the columns of UT2 X and U
T
2 Q span mutually
orthogonal subspaces within this (n − d)-dimensional space. Hence (n − d − p)σ2(X) =
tr(QTCQT) is the trace of C22 over the residual (n − d − p)-dimensional space orthogonal
to the latent variables, within the subspace orthogonal to the d known covariates. By the
Courant-Fisher min-max theorem for eigenvalues [25], the (n− d− p)-dimensional subspace
ofRn−d with smallest trace is the subspace spanned by the eigenvectors of C22 corresponding
to its (n− d− p) smallest eigenvalues. By Theorem 3, this is exactly the subspace obtained
by choosing X equal to the restricted maximum-likelihood solution Xˆ.
S7 Selecting covariates and the latent dimension
Two practical problems remain: how to choose the latent variable dimension parameter p
and which known covariates to include?
To choose p, we will use the following result:
Lemma 7.
tr(C) = tr(Kˆ) = tr(ZBˆZT) + tr(XˆAˆXˆT) + nσˆ2
Proof. Use Theorem 4 to compute
tr(ZBˆZ) = tr
(
U1Γ1VT
[
VΓ−11 (C11 − σˆ21)Γ−11 VT
]
VΓ1UT1
)
= tr
(
U1C11UT1
)− σˆ2 tr(U1UT1 )
= tr(C11)− dσˆ2,
where the last step uses the cyclical property of the trace and the fact that UT1 U1 = 1d.
Likewise, we have
tr
(
XˆAˆXˆ
)
= tr
(
U2Wp diag(λ1, . . . ,λp)WTp U
T
2
)
− σˆ2 tr(U2WpWTp UT2 )
=
p
∑
j=1
λj − pσˆ2
=
n−d
∑
j=1
λj − (n− d)σˆ2
= tr(C22)− (n− d)σˆ2.
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Hence
tr(Kˆ) = tr(ZBˆZ) + tr(XˆAˆXˆ) + nσˆ2 = tr(C11) + tr(C22) = tr(C)
Because C = (YYT)/m, the eigenvalues of C are (proportional to) the squared singular
values of the expression data Y. Hence tr(ZBˆZ)/ tr(C) is the proportion of variation in Y
explained by the known covariates, tr(XˆAˆXˆ)/ tr(C) the proportion of variation explained
by the latent variables, and nσˆ2/ tr(C) is the residual variance.
Our method for determining the number of latent variables lets the user decide a priori the
minimum amount of variation ρ in the data that should be explained by the known and
latent confounders. It follows that given ρ, a “target” value for σ2 is
σ2(ρ) = min
{ (1− ρ) tr(C)
n
,λmin(C11)
}
,
where the minimum with λmin(C11) is taken to ensure that of condition (S25) remains valid.
Because the eigenvalues λ1, . . . ,λn−d are sorted, the function
f (p) =
1
n− d− p
n−d
∑
j=p+1
λj
increases with decreasing p. Hence given ρ, we define pˆ as
pˆ = min
{
p : 0 ≤ p < n− d,λp > λn−d, f (p) < σ2(ρ)
}
,
that is, we choose pˆ to be the smallest number of latent variables that explain at least a propori-
tion of variation ρ of Y, while guaranteeing that the conditions for all mathematical results
derived in this document are valid.
Note that unless all eigenvalues of C22 are identical, pˆ always exists. Once the desired num-
ber of latent variables pˆ is defined, the latent factors Xˆ, the variance parameters Aˆ, and the
residual variance estimate σˆ2 (which will be the largest possible value less than or equal
to the target value σ2(ρ)) are determined by Theorem 3. Once those are determined, the
remaining covariance parameters Bˆ and Dˆ are determined by Theorem 4.
A second practical problem occurs when the rank of Z exceeds the number of samples, such
that any subset of n linearly independent covariates explains all of the variation in Y. To
select a more relevant subset of covariates, we rapidly screen all candidate covariates using
the model with a single known covariate (Section S4) to compute the variance βˆ2 explained
by that covariate alone (eq. (S15)). We then keep only those covariates for which βˆ2 ≥ θ tr(C),
where θ > 0 is the second free parameter of the method, namely the minimum amount of
variation explained by a known covariate on its own. The selected covariates are ranked
according to their value of βˆ2, and a linearly independent subset is generated, starting from
the covariates with highest βˆ2.
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